Joy Goswami, MS, MBA, RTTP Office of Economic Innovation & Partnerships University of Delaware 2012 TTOs facing all round budget cuts Being confronted with issues such as down-sizing their patent portfolios to prioritize focus on the more ‘licensable’ patents Number of new invention disclosures being received is on the rise but proportionally, the number of license deals are NOT Requirements to develop a more structured screening process to reduce accrual of ‘non-licensable’ patents Demands to increase efficiency of already under-staffed and overworked offices! What is triage? Major elements of triage Properties of a triage tool Interpretation of ‘licensable’ technology In the shoes of potential licensee 6. Objectives defined 7. Decision matrix 8. Interpretation of the Decision Matrix 9. Proposed Model for adoption (9-month rule) 10. Conclusion ‘licensable’ technologies 1. 2. 3. 4. 5. Triage is: Preliminary screening assessment undertaken in an effort to …. Identify high potential projects that may be worthy of significant effort and investment in commercialization. AUTM- 09 US Licensing Activity Survey reported 20,309 disclosures 4,374 licenses executed 18,214 total U.S. patent applications filed Legality Safety Environmental impact Societal impact Potential market Product life cycle Usage learning Product visibility Service Durability New competition Functional feasibility Production feasibility Stability of demand Consumer/user compatibility Marketing research Distribution Perceived function Existing competition Potential sales Development status Investment costs Trend of demand Product sales Development status Investment costs Trend of demand Product line potential Need Promotion Appearance Price Protection Payback period Profitability Product interdependence R&D University of Oregon’s Innovation Center (1970s) developed a list of 33 areas and factors that should be determined for commercial potential of invention. Desired: Objective analysis Not ranking based Simple to use and apply Easy and reliable interpretation of results 1. 2. 3. 4. Commonly known tools: TechAccess ™ (Texas A&M) TechAdvance™ point system, based on 43 researched and validated criteria, provides an easy-to-use system for ranking your technologies Innovation Assessment Program at Washington State University Others: mostly from commercial organizations Triage is the preliminary screening assessment undertaken by us in an effort to identify high potential projects (‘licensable technologies’ ) that may be worthy of significant effort and investment in commercialization. “We do not want to leave any scope of MAYBE in our assessment here” An invention that is legally protectable. Is relevant to a market need (has commercial value) Can be envisioned as a material product (mature) Is supported by inventors showing willingness to facilitate ‘technology transfer’ What Licensees really want from the technology: Freedom to operate Barriers to Entry Threats to Substitute Minimize Risk ‘Good’ Competitive Technology Value Extraction Consideration What Licensees really want from the technology: Market Strength Develop technological capability Concentrate on opportunity (in-license) Strong Buy technology Average Keep out Look for opportunities Strengthen marketing function Weak Keep out Find niche Look for partners Weak Average Strong Technological capability 1. Licensing Revenue 2. Sponsored Research 3. University – Industry Partnership development 4. Start-ups (Spin-outs and Spin-ins) 5. Economic Development Patents are the media and NOT the end point for success Even best patents might not be licensable Patents can be obtained for almost everything if aimed low at claims Defining a ‘good’ versus ‘bad’ patent is subjective but important ‘Good’ Patent = Licensable ; ‘Bad’ Patent = Non-licensable All disclosures mandates close scrutiny and good screening to get ‘good’ patents THE DECITION MATRIX 1. Very clear idea of the invention (technology for protection) 2. Precise idea of what the end (commercial) product will look like 3. Value Proposition: Faster/ Better/Cheaper (1992 NASA initiative) 4. Inventor(s) background Receive well documented invention disclosures that: Describes invention clearly and concisely. Highlight why it is unique, non-obvious and useful Attach all prior patent art, literature, citations Mention Funding Source and Agencies State the invention’s commercial value (with justifications) Attach all commercial contacts (names/addresses) that may be interested in the invention List Inventors (each inventor having at least one contribution to the patent claims) Step 1 Preliminary Screening Step 2 Implement Decision Matrix Step 1 Preliminary Screening Look for non-favorable ‘licensing characteristics’ (commonality in disclosures that have been not been successfully licensed in the past). One size does not fit all… Screen-out disclosures that have such non-favorable ‘licensing characteristics’. Some of these characteristics include: ▪ ▪ ▪ ▪ ▪ Simple artifacts, involve rudimentary use of scientific principles Disclosures involving know-how or process only (and not part of a portfolio) Comprise non-cooperative inventors Have specific and narrow application base Is not amongst the list of emerging technologies* Advanced Materials Superconductors Advanced semiconductor devices Digital Imaging Technology High Density Data Storage High-performance computing Optoelectronics Artificial Intelligence Flexible computer-integrated manufacturing Sensor technology Chemical Engineering Agriculture and Plant Science Medicine Biotechnology Medical devices and diagnostics (Source: Technology Administration Division, US Department of Commerce) Step 2 Implement Decision Matrix 1. Patentability 2. Commercial Viability 3. Stage of Technology Maturity Protectable Invention (IP) Commercial Value Decision Matrix Maturity Good (Licensable) Patent Category Patentability Marketability Maturity Stage Go/No-Go Activity I Narrow Low Early or Late No-Go Abandon or Assign rights back to inventors Broad Low Early or Late No-Go Abandon or Assign rights back to inventors 3 Narrow High Early Further diligence required Seek collaborators for sponsored research 4 Narrow High Late Go Seek Licensee with nonexclusivity terms 5 Broad High Early Go Actively seek licensee with option terms 6 Broad High Late Go Actively seek licensee for exclusivity 2 Protectable Invention (IP) Commercial Value Maturity Good (Licensable) Patent 1. To what extent has the invention already been disclosed to the public? (i.e. is it novel) 2. Obviousness - TSM test, an invention is obvious (and therefore unpatentable) only if there is a teaching, suggestion or motivation to combine prior art references. 3. Anticipated scope of claims? Rate: Broad or Narrow Protectable Invention (IP) Commercial Value Maturity Good (Licensable) Patent 1. Nature of the technology in the market: breakthrough or incremental improvement? 2. Competitive products: currently available in the market? 3. Market Assessment: size, fields of use, company players? 4. Value Proposition: Does the added value exceed the cost of development? Rate: High or Low Protectable Invention (IP) 1. Commercial Value Maturity Anticipated time to license? Rate: Early or Late Good (Licensable) Patent Category Patentability Marketability Maturity Stage Go/No-Go Activity I Narrow Low Early or Late No-Go Abandon or Assign rights back to inventors Category 2 Patentability Marketability Maturity Stage Go/No-Go Activity Broad Low Early or Late No-Go Abandon or Assign rights back to inventors Category Patentability Marketability Maturity Stage Go/No-Go Activity 3 Narrow High Early Further diligence required Seek collaborators for sponsored research Category Patentability Marketability Maturity Stage Go/No-Go Activity 4 Narrow High Late Go Seek Licensee with nonexclusivity terms Category Patentability Marketability Maturity Stage Go/No-Go Activity 5 Broad High Early Go Actively seek licensee with option terms Category Patentability Marketability Maturity Stage Go/No-Go Activity 6 Broad High Late Go Actively seek licensee for exclusivity Category Patentability Marketability Maturity Stage Go/No-Go Activity I Narrow Low Early or Late No-Go Abandon or Assign rights back to inventors Broad Low Early or Late No-Go Abandon or Assign rights back to inventors 3 Narrow High Early Further diligence required Seek collaborators for sponsored research 4 Narrow High Late Go Seek Licensee with nonexclusivity terms 5 Broad High Early Go Actively seek licensee with option terms 6 Broad High Late Go Actively seek licensee for exclusivity 2 Category Patentability Marketability Maturity Stage Go/No-Go Activity I Narrow Low Early or Late No-Go Abandon or Assign rights back to inventors Broad Low Early or Late No-Go Abandon or Assign rights back to inventors 3 Narrow High Early Further diligence required Seek collaborators for sponsored research 4 Narrow High Late Go Seek Licensee with nonexclusivity terms 5 Broad High Early Go Actively seek licensee with option terms 6 Broad High Late Go Actively seek licensee for exclusivity 2 Getting market ‘cues’ is most critical for fruitful decision making 1. 2. 3. 4. 5. 6. Enforcement Licensing Opportunity Licensing Opportunistic Licensing Divestiture licensing Partnering Licensing Startup Licensing Identify sensitivity of the technology to various risks: Technology itself The market IP issues Government and society Consider economics Identify application fit to an unmet need Review production capacity Study scale-up or mass production feasibility “9 months rule” – No conversion unless favorable marketability response Invention disclosure submitted to TTO Decision to convert or abandon: 9 months Provisional Filed: 0 months Review disclosure using DECISION MATRIX “Marketing Active” Prepare technical flyer, Assess target market and contact companies (20 +), review start-up interest assess technology and gather data Within the 9 month period of provisional filing: 1. 2. 3. Perform ‘push’ marketing to pertinent target market Collect data (positive, negative and no responses) Analyze data in light of the decision matrix to determine conversion decision Patent Prosecution: 12 months Companies (Potential Licensees) Alumni (Expert Network) VCs and Entrepreneurs TTO Current Licensees University ‘Excels’ Inventors USE INTERNET AS THE PRIMARY TOOL Contact Potential Licensees Follow up Ensure receipt by phone or e-mail Respond to requests for more info in a timely manner E-mail first If a known contact, either e-mail or call, but respect their time. Have a draft CDA ready to send out within a day of the request Call faculty to get answers to speed up response to the company Keep complete records of your marketing activities (data collection) Lots of good ideas are patentable but may not be licensable Take a comprehensive approach to your screening process Identify ‘good’ (licensable) technologies using a well designed triage tool Define your objectives (… merely getting patents is NOT an objective) Get all critical pieces of the invention Adopt a simple two-step triage process comprising of preliminary screening , and decision matrix Step 1 Preliminary Screening Step 2 Implement Decision Matrix Decision matrix comprising of a minimum of the three criteria: patentability, marketability and stage of maturity Analyze – go or no-go (no intermediates) Capitalize on the provisional period to gather data (market cues) Lowe Paul. The Management of Technology – Perception and Opportunities: 1st edition. Chapman & Hall, 1995 Kotler, Philip and Kevin Lane Keller. Marketing Management, 12th edition. Upper Saddle River, NJ: Prentice Hall, 2006 Razgaitis, Richard. Valuation and Pricing of Technology – Based Intellectual Property, 2nd edition. Hoboken, NJ: John Wiley and Sons, Inc., 2003. Christopher M. Arena and Eduardo M. Carreras. The Business of intellectual Property. 1st edition. Oxford University Press, 2008. Stim Richard. License your invention – sell your idea and protect your rights with a solid contact. 3rd edition. Nolo, 2002 THANK YOU It is better to debate a question without settling than to settle a question without debating it. -Jeseph Joubert Joy Goswami (MS, MBA, RTTP) Licensing Associate Registered Technology Transfer Practitioner University of Delaware Office of Economic Innovation & Partnerships 1, Innovation Way, Suite 500 Delaware Technology Park Newark, DE 19711 Phone: 302-650-9710 (Cell) Fax: 302-831-3411 Web: www.udel.edu/oeip